Sage Therapeutics Inc. (SAGE)
Sage Therapeutics Statistics
Share Statistics
Sage Therapeutics has 62.62M shares outstanding. The number of shares has increased by 2.16% in one year.
| 62.62M |
| 2.16% |
| 0.5% |
| 84.29% |
| n/a |
| 1,218 |
| 0.12% |
Short Selling Information
The latest short interest is 5.01M, so 8.01% of the outstanding shares have been sold short.
| 5.01M |
| 8.01% |
| 8.92% |
| 5.46 |
Valuation Ratios
The PE ratio is -0.82 and the forward PE ratio is -2.36. Sage Therapeutics's PEG ratio is 0.03.
| -0.82 |
| -2.36 |
| 8 |
| 1.9 |
| 0.71 |
| -1.23 |
| 0.03 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Sage Therapeutics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 7.42, with a Debt / Equity ratio of 0.03.
| 7.42 |
| 7.42 |
| 0.03 |
| -0.03 |
| -0.04 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $116,835.69 |
| $-1,135,031.16 |
| 353 |
| 0.08 |
| n/a |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by -37.05% in the last 52 weeks. The beta is 0.17, so Sage Therapeutics's price volatility has been higher than the market average.
| 0.17 |
| -37.05% |
| 7.14 |
| 6.93 |
| 49.22 |
| 1,046,303 |
Income Statement
In the last 12 months, Sage Therapeutics had revenue of 41.24M and earned -400.67M in profits. Earnings per share was -6.59.
| 41.24M |
| 31.8M |
| -432.37M |
| -400.67M |
| -409.49M |
| -410.52M |
| -6.59 |
Balance Sheet
The company has 81.02M in cash and 11.84M in debt, giving a net cash position of 69.19M.
| 81.02M |
| 11.84M |
| 69.19M |
| -2.97B |
| 469.67M |
| 404.7M |
Cash Flow
In the last 12 months, operating cash flow was -267.19M and capital expenditures 0, giving a free cash flow of -267.19M.
| -267.19M |
| n/a |
| -267.19M |
| -4.4 |
Margins
Gross margin is 77.1%, with operating and profit margins of -1048.35% and -971.48%.
| 77.1% |
| -1048.35% |
| -971.48% |
| -971.48% |
| -992.86% |
| -1048.35% |
| -647.85% |
Dividends & Yields
SAGE does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for SAGE is $8.5, which is 25.4% higher than the current price. The consensus rating is "Hold".
| $8.5 |
| 25.4% |
| Hold |
| 17 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| -6.34 |
| 2 |